CoQ10 vs Nattokinase
A side-by-side research comparison of CoQ10 and Nattokinase across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | CoQ10 | Nattokinase |
|---|---|---|
| Full name | Coenzyme Q10 (Ubiquinol) | Nattokinase (Subtilisin NAT) |
| Category | Cardiovascular | Cardiovascular |
| Status | Dietary supplement | Dietary supplement |
| Mechanism | Shuttles electrons in the mitochondrial respiratory chain (Complex I→III). As ubiquinol, neutralizes lipid peroxyl radicals protecting cell membranes and LDL from oxidation. Restores mitochondrial membrane potential. | Directly degrades fibrin in blood clots via proteolytic activity. Also activates endogenous tissue plasminogen activator (tPA) and suppresses plasminogen activator inhibitor-1 (PAI-1), enhancing the body's own fibrinolytic system. |
| Molecular weight | 863.34 Da | ~27,728 Da |
| Half-life | ~33 hours (ubiquinol) | ~8-12 hours (fibrinolytic activity) |
| Bioavailability | ~6-9% (standard); ~300% improved with ubiquinol/lipid formulations | Oral absorption confirmed; survives GI tract |
| Typical dose | 100-300 mg ubiquinol | 2000-4000 FU (fibrinolytic units) |
| Frequency | Daily with fat-containing meal | Daily on empty stomach |
| Route | Oral softgel | Oral capsule |
CoQ10 reported benefits
- Mitochondrial energy production
- Cardiac function support
- Antioxidant protection
- Statin side effect mitigation
- Exercise performance
- Fertility support (egg/sperm quality)
Nattokinase reported benefits
- Fibrin clot dissolution
- Blood pressure reduction
- Improved blood viscosity
- Reduced DVT risk
- Atherosclerosis prevention
- Natural anticoagulant alternative
Related comparisons
Research and educational reference only. Not medical advice.